Free Trial

Marsh & McLennan Companies (NYSE:MRSH) Trading Down 13.1% After Analyst Downgrade

Marsh & McLennan Companies logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Marsh & McLennan shares fell 13.1% after Piper Sandler cut its price target from $190 to $182 and kept a neutral rating. The stock traded as low as $180.97 and saw heavier-than-normal volume.
  • Other analysts also trimmed targets recently, though the overall Street view remains cautious: the stock currently carries an average “Hold” rating with a consensus price target of $203.56.
  • The company recently reported better-than-expected quarterly results, with EPS of $3.29 versus the $3.21 estimate and revenue up 7.6% year over year to $7.30 billion.
  • Five stocks to consider instead of Marsh & McLennan Companies.

Marsh & McLennan Companies, Inc. (NYSE:MRSH - Get Free Report)'s stock price was down 13.1% on Wednesday after Piper Sandler lowered their price target on the stock from $190.00 to $182.00. Piper Sandler currently has a neutral rating on the stock. Marsh & McLennan Companies traded as low as $180.97 and last traded at $160.6980. Approximately 3,040,356 shares traded hands during trading, an increase of 19% from the average daily volume of 2,555,264 shares. The stock had previously closed at $185.00.

Several other equities analysts also recently weighed in on the stock. JPMorgan Chase & Co. lowered their price target on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an "overweight" rating on the stock in a report on Thursday, April 9th. Barclays lowered their price target on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an "overweight" rating on the stock in a report on Wednesday, April 8th. Royal Bank Of Canada reaffirmed a "sector perform" rating and set a $200.00 price target on shares of Marsh & McLennan Companies in a report on Friday, January 30th. Mizuho lowered their price target on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a "neutral" rating on the stock in a report on Monday, April 13th. Finally, Raymond James Financial raised shares of Marsh & McLennan Companies from an "outperform" rating to a "strong-buy" rating and set a $225.00 price target on the stock in a report on Tuesday, February 17th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Marsh & McLennan Companies presently has an average rating of "Hold" and an average target price of $203.56.

View Our Latest Report on MRSH

Insider Activity

In other news, CEO John Q. Doyle sold 16,655 shares of Marsh & McLennan Companies stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the sale, the chief executive officer owned 116,811 shares in the company, valued at $21,411,456.30. This trade represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.38% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Marsh & McLennan Companies

Several large investors have recently bought and sold shares of MRSH. Brighton Jones LLC increased its position in Marsh & McLennan Companies by 51.2% in the fourth quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider's stock worth $1,856,000 after purchasing an additional 2,960 shares during the last quarter. Bison Wealth LLC increased its position in Marsh & McLennan Companies by 39.6% in the fourth quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider's stock worth $651,000 after purchasing an additional 869 shares during the last quarter. Glenview Trust co increased its position in Marsh & McLennan Companies by 10.8% in the second quarter. Glenview Trust co now owns 3,897 shares of the financial services provider's stock worth $852,000 after purchasing an additional 379 shares during the last quarter. Osterweis Capital Management Inc. increased its position in Marsh & McLennan Companies by 18,440.0% in the second quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider's stock worth $203,000 after purchasing an additional 922 shares during the last quarter. Finally, Diversify Advisory Services LLC bought a new stake in Marsh & McLennan Companies in the second quarter worth $1,307,000. Institutional investors own 87.99% of the company's stock.

Marsh & McLennan Companies Price Performance

The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11. The company has a market cap of $77.14 billion, a P/E ratio of 19.96, a PEG ratio of 2.34 and a beta of 0.65. The firm's 50-day moving average is $165.50 and its two-hundred day moving average is $172.43.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last posted its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, beating analysts' consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The business had revenue of $7.30 billion for the quarter. The company's revenue for the quarter was up 7.6% compared to the same quarter last year. Analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current year.

Marsh & McLennan Companies Company Profile

(Get Free Report)

Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Marsh & McLennan Companies Right Now?

Before you consider Marsh & McLennan Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.

While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines